AnnouncementsGlenmark Pharma receives USD 5 million from Sanofi
100% of moneycontrol users recommend selling Glenmark.
What's your call on Glenmark today?
Read 6 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2565.45||0.50||2939.80||1999.40||43,640.58|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
Glenmark is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 15,467.88 crore.The company has reported a consolidated sales of Rs 1,601.22 crore and a Net Profit of Rs 214.33 crore for the quarter ended Dec 2013.
The company management includes Glenn Saldanha - Chairman & Managing Director, Rajesh V Desai - Executive Director & CFO, Cherylann Pinto - Director - Corporate Affairs, D R Mehta - Non Executive Director, Bernard Munos - Non Executive Director, J F Ribeiro - Non Executive Director, Brian W Tempest - Non Executive Director, Sridhar Gorthi - Non Executive Director, Hocine Sidi Said - Non Executive Director, N B Desai - Non Executive Director.
It is listed on the BSE with a BSE Code of 532296 and the NSE with an NSE Code of GLENMARK.
Its Registered office is at B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai,Maharashtra - 400026.
Their Registrars are Karvy Computershare Private Ltd.